Feedback / Questions
COYA 301 - Coya Therap
https://www.businesswire.com/news/home/20230215005211/en/Coya-Therapeutics-Inc.-Announces-Expansion-of-Exclusive-Worldwide-Licensing-Agreement-with-ARScience-Biotherapeutics-Inc.-for-Development-and-Commercialization-of-COYA-301-Coya%E2%80%99s-Low-Dose-Interleukin-2-IL-2-Product-Candidate
Feb 15, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next